期刊文献+

肾脏替代治疗前列腺癌骨转移伴高钙血症及多器官功能障碍1例 被引量:2

原文传递
导出
摘要 本文报道1例前列腺癌伴发热的患者在住院过程中出现多脏器功能障碍,明确系高钙危象导致,给予药物联合肾脏替代治疗后血钙下降、病情好转。恶性肿瘤合并高钙血症较常见,但前列腺癌合并高钙危象并不常见。对于恶性肿瘤患者应动态监测血钙水平变化,避免漏诊及延迟治疗。对高钙危象患者在药物保守治疗的基础上应积极采取肾脏替代治疗措施。
出处 《中华医学杂志》 CAS CSCD 北大核心 2022年第40期3213-3214,共2页 National Medical Journal of China
基金 北京市临床重点专科卓越项目(京卫医[2021]135号)。
  • 相关文献

参考文献1

二级参考文献14

  • 1Phitayakom R, Mchenry CR. Hyperparathyroid crisis: use of bisphos?phonates as a bridge to parathyroidectomy. J Am CoIl Surg,2008 ,206: 1106-1115.
  • 2Pall an S, Rahman MO, Khan AA. Diagnosis and management of primary hyperparathyroidism. BMJ ,2012 ,344 : e 1 0 13.
  • 3Mundy GR, Edwards JR. PTH-related peptide ( PTHrP) in hypercalce?mia. J Am Soc Nephrol,2008, 19 :672-675.
  • 4Al-Azem H, Khan A. Primary hyperparathyroidism. CMAJ, 2011 , 183: E685-E689.
  • 5Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician ,2003,67: 1959-1966.
  • 6Major P , Lortholary A, Hon J ,et a1. Zoledronic acid is superior to pam?idronate in the treatment of hypercalcemia of malignancy: a pooled anal?ysis of two randomized, controlled clinical trials. J Clin Oncol, 2001 , 19:558-567.
  • 7Kawada K, Minami H, Okabe K, et a1. A multicenter and open lahel clinical trial of zoledronic acid 4mg in patients with hypercalcemia of malignancy. Jpn J Clin Oncol,2005 ,35 :28-33.
  • 8Bech A, Smolders K, Telting D, et al. Cinacalcet for hypercalcemia caused by pulmonary squamous cell carcinoma producing parathyroid hormone-related Peptide. Case Rep Oneal ,2012,5: 1-8.
  • 9Stopeck AT, Lipton A, Body JJ, et a1. Denosumab compared with zole?dronic acid for the treatment of bone metastases in patients with ad?vanced breast cancer: a randomized, double-blind study. J Clin Oneal, 2010,28 :5132-5139.
  • 10Clines GA. Mechanisms and treatment of hypercalcemia of malignancy. CUlT Opin Endocrinol Diabetes Obes,20]] ,18 :339-346.

共引文献15

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部